Israel Englander Kala Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $11.7 $3,556 - $166,455	-14,227 Reduced 2.49%	557,962 $124,000
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.31 $156,656 - $684,067	522,189 Added 1044.38%	572,189 $172,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $7,851 - $23,684	-12,872 Reduced 20.47%	50,000 $69,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $104,793 - $247,528	-90,339 Reduced 58.96%	62,872 $76,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $327,054 - $677,826	124,830 Added 439.84%	153,211 $401,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $3.4 Million - $5.48 Million	-672,294 Reduced 95.95%	28,381 $150,000
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $787,662 - $1.21 Million	-126,228 Reduced 15.27%	700,675 $4.72 Million
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $3.38 Million - $4.73 Million	537,972 Added 186.19%	826,903 $5.61 Million
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $509,197 - $754,291	-67,893 Reduced 19.03%	288,931 $2.17 Million
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $4.04 Million - $6.69 Million	-485,029 Reduced 57.61%	356,824 $3.75 Million
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $1.12 Million - $2.58 Million	293,383 Added 53.49%	841,853 $7.4 Million
Q4 2019 Feb 14, 2020	SELL	$3.36 - $4.81 $39,147 - $56,041	-11,651 Reduced 2.08%	548,470 $2.02 Million
Q3 2019 Nov 14, 2019	SELL	$3.57 - $6.58 $30,273 - $55,798	-8,480 Reduced 1.49%	560,121 $2.13 Million
Q2 2019 Aug 15, 2019	BUY	$4.93 - $8.8 $2.6 Million - $4.65 Million	527,988 Added 1300.05%	568,601 $3.63 Million
Q2 2019 Aug 14, 2019	SELL	$4.93 - $8.8 $3.77 Million - $6.73 Million	-764,213 Reduced 94.95%	40,613 $4.36 Million
Q1 2019 May 14, 2019	BUY	$5.19 - $8.97 $3.34 Million - $5.77 Million	643,785 Added 399.76%	804,826 $6.66 Million
Q4 2018 Feb 14, 2019	SELL	$4.29 - $9.94 $993,568 - $2.3 Million	-231,601 Reduced 58.99%	161,041 $787,000
Q3 2018 Nov 14, 2018	SELL	$9.54 - $13.87 $1.97 Million - $2.86 Million	-206,308 Reduced 34.44%	392,642 $3.88 Million
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $5.31 Million - $6.98 Million	-399,369 Reduced 40.0%	598,950 $8.22 Million
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $11 Million - $17 Million	894,919 Added 865.49%	998,319 $15.8 Million
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $569,594 - $964,729	41,637 Added 67.41%	103,400 $1.91 Million
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $1.23 Million - $1.64 Million	61,763	61,763 $1.41 Million

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$5
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account